Home › Companies › Nuvation Bio Inc. › 2025-2026

Nuvation Bio Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Nuvation Bio Inc.’s Form 8-K, filed May 27, 2026 (Item 5.07 on EDGAR). Page generated October 25, 2026.

4Ballot items
194Asset managers
969Fund votes
May 21, 2026Meeting date

Results at a glance

Meeting of May 21, 2026: 4 items on Nuvation Bio Inc.’s Form 8-K, filed May 27, 2026: 2 elected · 2 approved.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2024-2025 2025-2026

Explore Nuvation Bio Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Nuvation Bio Inc.

These tallies are Nuvation Bio Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 27, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Nuvation Bio Inc. — official shareholder meeting results, meeting held May 21, 2026
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Support (of votes cast)	Reported outcome	Voting standard
Elect Director: Robert B. Bazemore, Jr.	197,674,280	--	--	37,655,082	55,602,434	84%	Elected	—
Elect Director: Robert Mashal, M.D.	216,772,840	--	--	18,556,522	55,602,434	92%	Elected	—
2. Ratification of Independent Registered Public Accounting Firm	290,273,104	413,176	245,516	--	0	99.8%	Approved	—
3. To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement	230,050,644	4,950,024	328,694	--	55,602,434	98%	Approved	—

Source: Nuvation Bio Inc., Form 8-K, filed with the SEC on May 27, 2026 — read the filing on EDGAR.

How asset managers voted at the Nuvation Bio Inc. 2025-2026 meeting

Each item below shows how the 194 asset managers that disclosed a Nuvation Bio Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Robert B. Bazemore, Jr.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 6 wordings of this item as funds reported it.

84% Majority: yes · of votes cast

FOR 84%WITHHELD

FOR: 197,674,280WITHHELD: 37,655,082

Details: description as filed, official tally, votes by 54 asset managers

Description as filed by funds: Election of Directors: Robert Bazemore

Nuvation Bio Inc.’s own tally for this item (“Elect Director: Robert B. Bazemore, Jr.”): 197,674,280 for, 37,655,082 withheld, per its Form 8-K filed May 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The individuals listed below were elected at the Annual Meeting to serve as directors of the Company until the Company's 2029 annual meeting of stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal.”
Support: 84% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 54 asset managers below reported 47,594,110 for, 13,634,955 withheld, 100,098 abstained.

FORWITHHOLD

FOR: 47,594,110ABSTAIN: 100,098WITHHOLD: 13,634,955

Largest asset managers voting on “Election of Directors: Robert Bazemore” at Nuvation Bio Inc., 2025-2026
Asset manager	For	Abstain	Withheld	Vote
Fidelity	23,708,791	0	4,990,567	Mixed
Vanguard	13,681,217	20,365	9,611	For
BlackRock	7,249,158	0	0	For
American Century	0	0	2,196,254	Withhold
Charles Schwab	0	0	1,963,390	Withhold
TIAA	0	0	1,186,668	Withhold
State Street	573	0	611,295	Withhold
Equitable	347,452	0	148,580	Mixed
TANAKA FUNDS INC	485,000	0	0	For
T. Rowe Price	446,082	0	0	For
AIG/SunAmerica	0	0	394,982	Withhold
Tema ETF Trust	390,195	0	0	For
QUANTITATIVE MASTER SERIES LLC	375,087	0	0	For
SEI	0	0	340,055	Withhold
Dimensional	0	0	298,894	Withhold
ALPS ETF Trust	0	0	287,737	Withhold
Lincoln Financial	0	0	282,091	Withhold
Invesco	196,672	0	0	For
Brighthouse	77,574	0	72,553	Mixed
BUFFALO FUNDS	147,221	0	0	For
SEI Exchange Traded Funds	0	0	135,730	Withhold
Northern Trust	0	0	119,420	Withhold
Global X	0	0	112,780	Withhold
Bridge Builder Trust	103,158	0	0	For
MASTER INVESTMENT PORTFOLIO	95,161	0	0	For

Showing the 25 largest of 54 asset managers. See all 54 in the interactive database.

2. Elect Director: Robert Mashal, M.D.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 6 wordings of this item as funds reported it.

92% Majority: yes · of votes cast

FOR 92%

FOR: 216,772,840WITHHELD: 18,556,522

Details: description as filed, official tally, votes by 54 asset managers

Description as filed by funds: Election of Directors: Robert Mashal, M.D.

Nuvation Bio Inc.’s own tally for this item (“Elect Director: Robert Mashal, M.D.”): 216,772,840 for, 18,556,522 withheld, per its Form 8-K filed May 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The individuals listed below were elected at the Annual Meeting to serve as directors of the Company until the Company's 2029 annual meeting of stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal.”
Support: 92% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 54 asset managers below reported 56,141,835 for, 5,109,663 withheld, 77,665 abstained.

FOR

FOR: 56,141,835ABSTAIN: 77,665WITHHOLD: 5,109,663

Largest asset managers voting on “Election of Directors: Robert Mashal, M.D.” at Nuvation Bio Inc., 2025-2026
Asset manager	For	Abstain	Withheld	Vote
Fidelity	28,699,358	0	0	For
Vanguard	13,711,164	29	0	For
BlackRock	7,249,158	0	0	For
American Century	0	0	2,196,254	Withhold
Charles Schwab	1,963,390	0	0	For
TIAA	0	0	1,186,668	Withhold
State Street	611,366	0	502	For
Equitable	347,452	0	148,580	Mixed
TANAKA FUNDS INC	485,000	0	0	For
T. Rowe Price	446,082	0	0	For
AIG/SunAmerica	0	0	394,982	Withhold
Tema ETF Trust	390,195	0	0	For
QUANTITATIVE MASTER SERIES LLC	375,087	0	0	For
SEI	340,055	0	0	For
Dimensional	0	0	298,894	Withhold
ALPS ETF Trust	0	0	287,737	Withhold
Lincoln Financial	164,600	0	117,491	Mixed
Invesco	196,672	0	0	For
Brighthouse	77,574	0	72,553	Mixed
BUFFALO FUNDS	147,221	0	0	For
SEI Exchange Traded Funds	135,730	0	0	For
Northern Trust	119,420	0	0	For
Global X	112,780	0	0	For
Bridge Builder Trust	103,158	0	0	For
MASTER INVESTMENT PORTFOLIO	95,161	0	0	For

Showing the 25 largest of 54 asset managers. See all 54 in the interactive database.

3. 3. To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the…

Official result Fund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 9 wordings of this item as funds reported it.

98% Approved · of votes cast

FOR 98%

FOR: 230,050,644AGAINST: 4,950,024

Details: description as filed, official tally, votes by 194 asset managers

Description as filed by funds: To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement.

Nuvation Bio Inc.’s own tally for this item (“3. To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement”): 230,050,644 for, 4,950,024 against — passed, per its Form 8-K filed May 27, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 55 asset managers voting on “To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in t” at Nuvation Bio Inc., 2025-2026
Asset manager	For	Against	Abstain	Vote
Fidelity	28,699,358	0	0	For
Vanguard	13,711,189	4	0	For
BlackRock	7,249,158	0	0	For
American Century	0	2,196,254	0	Against
Charles Schwab	1,963,390	0	0	For
TIAA	1,186,668	0	0	For
State Street	611,844	24	0	For
Equitable	496,032	0	0	For
TANAKA FUNDS INC	485,000	0	0	For
T. Rowe Price	446,082	0	0	For
AIG/SunAmerica	394,982	0	0	For
Tema ETF Trust	390,195	0	0	For
QUANTITATIVE MASTER SERIES LLC	375,087	0	0	For
SEI	340,055	0	0	For
Dimensional	298,894	0	0	For
ALPS ETF Trust	287,737	0	0	For
Lincoln Financial	282,091	0	0	For
Invesco	0	196,672	0	Against
Brighthouse	150,127	0	0	For
BUFFALO FUNDS	147,221	0	0	For
SEI Exchange Traded Funds	135,730	0	0	For
Northern Trust	119,420	0	0	For
Global X	112,780	0	0	For
HUSSMAN INVESTMENT TRUST	0	0	105,000	Abstain
Bridge Builder Trust	103,158	0	0	For

Fund voting reports, all 55 managers: 58,901,365 for, 2,427,798 against, 105,000 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 158 asset managers voting on “To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in t” at Nuvation Bio Inc., 2025-2026
Asset manager	For	Against	Vote
Fidelity	47,104,003	0	For
Decheng Capital LLC	25,954,439	0	For
Omega Fund Management, LLC	8,081,089	0	For
Laurion Capital Management LP	7,768,289	0	For
BlackRock	6,653,115	41,646	For
GEODE CAPITAL MANAGEMENT, LLC	5,844,498	0	For
State Street	3,333,689	6,283	For
Redmile Group, LLC	3,153,256	0	For
Duquesne Family Office LLC	2,628,226	0	For
American Century	0	2,412,323	Against
Charles Schwab	1,966,771	0	For
Vanguard	1,948,992	0	For
ABRAMS CAPITAL MANAGEMENT, L.P.	1,270,504	0	For
Nuveen	1,233,825	0	For
Northern Trust	1,168,192	19,057	For
T. Rowe Price	1,146,913	0	For
Two Sigma	894,763	0	For
ALGERT GLOBAL LLC	664,788	0	For
Connor, Clark & Lunn Investment Management Ltd.	638,185	0	For
Beacon Pointe Advisors, LLC	585,051	0	For
SEI	558,093	0	For
Palo Alto Investors LP	508,846	0	For
Wellington	442,600	0	For
SILVERCREST ASSET MANAGEMENT GROUP LLC	428,848	0	For
AQR	419,644	0	For

Institutional-manager reports, all 158 managers: 128,296,993 for, 3,658,955 against, 45,962 abstained, 550 not voted. Showing the 25 largest; see all in the interactive database.

4. 2. Ratification of Independent Registered Public Accounting Firm

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 2 wordings of this item as funds reported it.

99.8% Approved · of votes cast

FOR 99.8%

FOR: 290,273,104AGAINST: 413,176

Details: description as filed, official tally, votes by 55 asset managers

Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026.

Nuvation Bio Inc.’s own tally for this item (“2. Ratification of Independent Registered Public Accounting Firm”): 290,273,104 for, 413,176 against — passed, per its Form 8-K filed May 27, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's stockholders ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 55 asset managers below reported 61,334,163 for.

FOR

FOR: 61,334,163

Largest asset managers voting on “RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCA” at Nuvation Bio Inc., 2025-2026
Asset manager	For	Vote
Fidelity	28,699,358	For
Vanguard	13,711,193	For
BlackRock	7,249,158	For
American Century	2,196,254	For
Charles Schwab	1,963,390	For
TIAA	1,186,668	For
State Street	611,868	For
Equitable	496,032	For
TANAKA FUNDS INC	485,000	For
T. Rowe Price	446,082	For
AIG/SunAmerica	394,982	For
Tema ETF Trust	390,195	For
QUANTITATIVE MASTER SERIES LLC	375,087	For
SEI	340,055	For
Dimensional	298,894	For
ALPS ETF Trust	287,737	For
Lincoln Financial	282,091	For
Invesco	196,672	For
Brighthouse	150,127	For
BUFFALO FUNDS	147,221	For
SEI Exchange Traded Funds	135,730	For
Northern Trust	119,420	For
Global X	112,780	For
Bridge Builder Trust	103,158	For
MASTER INVESTMENT PORTFOLIO	95,161	For

Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.

Largest Nuvation Bio Inc. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 346,503,675 shares outstanding at the time of that meeting.

Fund voting reports: top Nuvation Bio Inc. shareholders by shares voted on “To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as…”, 2025-2026
#	Asset manager	% of shares outstanding
1	Fidelity	8.28%
2	Vanguard	3.96%
3	BlackRock	2.09%
4	American Century	0.63%
5	Charles Schwab	0.57%
6	TIAA	0.34%
7	State Street	0.18%
8	Equitable	0.14%
9	TANAKA FUNDS INC	0.14%
10	T. Rowe Price	0.13%

Institutional-manager reports: top Nuvation Bio Inc. shareholders by shares voted on “To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as…”, 2025-2026
#	Asset manager	% of shares outstanding
1	Fidelity	13.59%
2	Decheng Capital LLC	7.49%
3	Omega Fund Management, LLC	2.33%
4	Laurion Capital Management LP	2.24%
5	BlackRock	1.93%
6	GEODE CAPITAL MANAGEMENT, LLC	1.69%
7	State Street	0.96%
8	Redmile Group, LLC	0.91%
9	Duquesne Family Office LLC	0.76%
10	American Century	0.70%

Reported Nuvation Bio Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

Nuvation Bio Inc. holdings and ownership disclosed for the 2025-2026 proxy season
Holder	% outstanding	Disclosure
David Hung, M.D.	17.11%	DEF14A
FMR (Fidelity)	15.00%	13F
Entities affiliated with FMR LLC	14.60%	DEF14A
Entities affiliated with Decheng Anbio Limited	7.49%	DEF14A
Min Cui, Ph.D.	7.49%	DEF14A
BlackRock	7.24%	13F
Vanguard Group	4.49%	13F
State Street	1.96%	13F
Geode Capital	1.69%	13F
Two Sigma	0.77%	13F

Percentages above are of 346,503,675 shares outstanding, as reported by Nuvation Bio Inc. on its Form 10-Q dated March 31, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Nuvation Bio Inc.’s 10-Q dated March 31, 2026. This page is a static snapshot rebuilt weekly on October 25, 2026; a live search always shows the current data.

At Nuvation Bio Inc.'s shareholder meeting held May 21, 2026, in the 2025-2026 proxy season, 194 asset managers reported how they voted on 4 ballot items in their SEC Form N-PX filings, covering 969 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as… — Nuvation Bio Inc.'s filing reports the proposal as approved, with 98% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Nuvation Bio Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 27, 2026.

Nuvation Bio Inc. proxy season coverage: 2024-2025 · 2025-2026 (this page).

Download data (CSV): ballot items · votes by manager · column guide.